These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7037980)

  • 21. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.
    Worcester EM; Coe FL; Evan AP; Parks JH
    BJU Int; 2006 Jun; 97(6):1285-90. PubMed ID: 16686727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers.
    Möhrke W; Knauf H; Mutschler E
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):447-52. PubMed ID: 9352394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the determination of triamterene, hydroxythiamterene and hydroxytriamterene sulphate ester in biologica material by direct evaluation of thin-layer chromatograms (author's transl)].
    Grebian B; Geissler HE; Mutschler E
    Arzneimittelforschung; 1976; 26(12):2125-7. PubMed ID: 1037260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Am J Kidney Dis; 2004 Nov; 44(5):799-805. PubMed ID: 15492945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triamterene nephrolithiasis: renewed attention is warranted.
    Carr MC; Prien EL; Babayan RK
    J Urol; 1990 Dec; 144(6):1339-40. PubMed ID: 2231920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of infrared spectrophotometry morpho-constitutional analysis of double J stent encrustations for indirect determination of urinary stone composition].
    Roupret M; Hupertan V; Daudon M; Lebrun S; Sebe P; Gattegno B; Thibault P; Traxer O
    Prog Urol; 2005 Jun; 15(3):411-5. PubMed ID: 16097144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nephrolithiasis caused by triamterene. Presentation of 2 cases].
    Piñango Angulo L; Gómiz de León JJ; Mialdea R; Traba ML; Alférez Villalobos C
    Actas Urol Esp; 1986; 10(2):119-22. PubMed ID: 3728117
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on the possible correlations between in vitro and in vivo data using commercial triamterene formulations (author's transl)].
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1980; 30(7):1158-63. PubMed ID: 7191300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis.
    Kang DE; Sur RL; Haleblian GE; Fitzsimons NJ; Borawski KM; Preminger GM
    J Urol; 2007 Apr; 177(4):1358-62; discussion 1362; quiz 1591. PubMed ID: 17382731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Triamterene-induced immune hemolytic anemia with acute intravascular hemolysis and acute renal failure (author's transl)].
    Takahashi H; Tsukada T
    Rinsho Ketsueki; 1979 Aug; 20(8):965-77. PubMed ID: 502012
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of the cardiac effects of triamterene and its phase II metabolite p-hydroxytriamterene sulphuric acid ester (author's transl].
    Greeff K; Schuhmacher P
    Arzneimittelforschung; 1979; 29(4):705-6. PubMed ID: 582773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excretion of triamterene and its metabolite in triamterene stone patients.
    Ettinger B
    J Clin Pharmacol; 1985; 25(5):365-8. PubMed ID: 4031113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triamterene calculus.
    Dickstein ES; Loeser WD
    J Urol; 1985 Jun; 133(6):1019. PubMed ID: 3999199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further studies on the natriuretic activity of p-hydroxytriamterene.
    Ackerman DM; DePalma PD; Shade M
    Arzneimittelforschung; 1982; 32(9):1023-5. PubMed ID: 6890818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nephrolithiasis caused by triamterene].
    Traba ML; Rapado A; Bonet F; Cifuentes-Delatte L
    Rev Clin Esp; 1984 Aug 15-31; 174(3-4):127-30. PubMed ID: 6515076
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urolithiasis].
    Piasecki Z; Wyczółkowski M
    Przegl Lek; 1998; 55(9):485-7. PubMed ID: 10085729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.